Cutting-edge cardiovascular science is set to change clinical practice in the Asia Pacific region: find out how at ESC Asia with APSC & AFC.
Covering the full spectrum of cardiology – prevention, imaging, arrhythmias, heart failure, intervention, and much more – during a comprehensive programme. Held 1 to 3 December in Singapore, the scientific congress is organised by the European Society of Cardiology (ESC), the Asian Pacific Society of Cardiology (APSC), and the Asean Federation of Cardiology (AFC). Explore the scientific programme.
Novel research will be presented in the scientific abstracts. Among them:
- Gender bias in the prevention of cardiovascular disease.
- Climate change and risk of stroke.
- Anxiety, sleep and heart disease progression.
- Effect of a lifestyle mobile app in patients with high blood pressure.
- Global trends in obesity, high blood pressure and diabetes in adults under 40.
- Parental history of heart disease and incidence of out-of-hospital cardiac arrest.
- Blood pressure lowering drugs and COVID-19.
The opening session1 features a lecture by Professor Terrance Chua of the National Heart Centre Singapore. Associate Professor Khung Keong Yeo, Scientific Committee Co-Chair said: “Get ready for an inspiring presentation on the role of risk scores for preventing heart disease and evaluating chest pain. He will also discuss the value of additional testing beyond risk scores and how this could be applied on a population basis.”
Key opinion leaders from across Europe and the Asia Pacific region will examine the hottest topics of the day in the scientific sessions. An entire session is devoted to controversies in heart failure.2 Experts will debate two major issues in clinical management. Professor Michel Komajda, Organising Committee Chair and Scientific Committee Co-Chair explained: “SGLT2 inhibitors benefit patients with heart failure regardless of ejection fraction, so the question is whether measurement of ejection fraction is still useful to guide use of this therapy or not. In addition, new ESC guidelines recommend initiation of four drug classes in heart failure with reduced ejection fraction.3 Here the practical question is whether we should start all four simultaneously or in sequence.”
Also on the agenda: hot topics in cardiac computed tomography (CT).4 Dr. Yeo said: “In this session, leading international figures will discuss several contemporary issues in cardiac CT. For example, we will hear how the CT scan may provide us more information beyond just a calcium score or stenosis, and potentially predict heart attacks.”
Regional differences in the management of cardiogenic shock in acute myocardial infarction will be highlighted in a dedicated session.5 “The use of mechanical support devices in acute myocardial infarction is an evolving area with new devices in clinical use,” noted Dr. Yeo. “In Asia, these devices are not commonly available and are very expensive.”
Not to miss: updates in transcatheter valve interventions.6 Dr. Yeo said: “It is thought that bicuspid aortic valve is more common in Asian compared with Western populations. We will also hear whether body size or other unique characteristics in Asia may influence patient management.”
Professor Komajda said: “Join us for a packed and stimulating programme. With original research in the abstracts showcasing scientific excellence from the Asia Pacific. Plus intense discussion on the how the latest scientific advances in cardiovascular medicine are set to impact patient care in the region. ESC Asia with APSC & AFC is the place to be – join us for an unforgettable event.”
Registration is free for journalists with an ESC Account. Mark your calendar and register now.
ENDS
Authors: ESC Press Office
Mobile: +33 (0)7 8531 2036
Email: press@escardio.org
Follow us on Twitter @ESCardioNews
Our mission: To reduce the burden of cardiovascular disease.